Expanded FDI in Indian pharma raises government concerns

11/18/2013 | Economic Times (India), The

Foreign direct investment in India's pharmaceutical industry hit $1.07 billion from April to August, nearly double 2012 figures, triggering government calls to impose new restrictions such as mandatory R&D investment. There is also widespread concern that foreign acquisitions will affect the availability and affordability of generic drugs. India routinely permits 100% foreign investment in new pharmaceutical projects, but acquisitions of existing companies require approval by the Foreign Investment Promotion Board.

View Full Article in:

Economic Times (India), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC